tbResList Print — DNR Daunorubicin

Filters: qv=472, qv2=%, rfv=%

Product

DNR Daunorubicin
Features: Chemotherapy Drug
Description: <p><b>Daunorubicin</b> - Anthracycline Chemotherapy</p>

<p><b>Recommended Abbreviation:</b> DNR</p>

<p><b>Alternative Names:</b> Daunomycin, Daunorubicin</p>

<p><b>Type:</b> Anthracycline antibiotic / topoisomerase II inhibitor / chemotherapy drug</p>

<p><b>Function:</b> Daunorubicin intercalates into DNA and inhibits topoisomerase II, preventing normal DNA strand breakage and religation during replication and transcription. It also generates reactive oxygen species and contributes to DNA damage, mitochondrial injury, and apoptosis.</p>

<p><b>Cancer:</b> Established anticancer drug used primarily in acute leukemias, including acute myeloid leukemia. Daunorubicin promotes DNA damage, topoisomerase II inhibition, oxidative stress, cell-cycle disruption, and apoptosis.</p>

Pathway results for Effect on Cancer / Diseased Cells

Total Targets: 0

Pathway results for Effect on Normal Cells

Total Targets: 0

Research papers

Year Title Authors PMID Link Flag